Member Info for PhatStyle4321

I agree great interview, and good questions, gives a very nice Birdseye view on what we have and what’s to be expected. I believe the excitement is just starting to bubble up.

TW has written an article on Skinbio on ShareP’s he makes a very interesting share price prediction by Xmas, suggest those to subscribe to see what that is but IMO it’s very sensible.

He may release over the weekend, Sunday maybe? Although in the meantime peeps should definitely subscribe.

Just hearing your comments makes it all worth while, once again how honoured I am to be invested in a company that helps people. Regardless of the share price, the fact that peoples ways of life will change for the good is enough for me. Absolutely wonderful

People make mistakes, but this mistake wasn’t fundamental, if the market wants to penalize than go ahead.

Who knows why they changed metrics, it could have been Croda, now there is no confusion.

It’s not that embarrassing, just a typo.

Happy that we have held at this price. Should be a slow build in price as the news is circulated. Extremely happy with what I have read and the scale could be massive here.

Regulatory approval in all major jurisdictions de risks the company further

Absolutely overwhelmed with the progress and efficiency of Stuart Ashman and SBTX. I have not known a company that absolutely hits the bullseye in every part of their projects but here they have.

Regulatory approval in the UK, US and EU ?!! - Amazing
£1.50 a sachet - wow.
Croda update all on target!

As always, just happy to be apart of a company that is helping people. Well done to all long term holders who have been through this magical journey

I say this every week, but one week down leaves us one week closer to commercialization. As long as everything is going to plan, i believe we should be targeting £1. However with an operation like this, it is not unusual for minor delays only the update can give us clarity.

Totally agree Belgrano, one of the reasons why I have invested is that the products help people. They help people to live a more free and painless life, with the absence of any side effects which is the key difference.

I also invested because I believe in the CEO’s passion and that he keeps to his promises.

Excited for the new few weeks over here on the update, obviously with operations such as these there can be a few delays here and there. However it would be a miracle if all is still going to plan. Time will tell, I will be holding for the foreseeable future. GLA.

Morning all,

Those that have listened to Stuart Ashman, know that he is a man of his word, and as of yet hasn’t let the market down. The minimum we will be getting is a pricing update, within 2/3 weeks. I believe if we are told that all things are going to plan as scheduled then it will take us to new heights.

Axis results took us to a high of 88p. Every week, every month draws us near to revenues, very material revenues. I believe we will surpass Opti revenues very very quickly. Time will tell, GLA, IMO, DYOR.

An update could drop anytime, i expect to see a lot of things re pricing strategy, regulatory approval, maybe a croda update… even to state that everything is on target is going to take us to the next level up IMO. Q4 is when the commercialization starts and every week that goes by puts us one week closer. 3 weeks left to Quarter 4 !!!

Strong demand here, awaiting the anticipated update re pricing which could be here at any moment.

It was stated within 3 months of the results of AxisBiotix.

This update could really be a game changer to notify shareholders on what progress has been made. Every week gets us closer to commercialisation.

Would also be interested to know how Croda production is progressing.

https://www.lse.co.uk/rns/CRDA/results-for-the-six-months-ended-30-june-2021-zaquv97iqjsd1t9.html

Link here if anyone wants to take a look

To be specific this was an update from Croda International, from my opinion it seems to be doing extremely well which bodes good for us.

Demand from Personal Care customers strengthened during the half year, particularly in luxury and premium markets. This benefitted our Beauty Actives business, the leading innovator in the global skin care market, which increased sales by 26%. Beauty Effects saw a progressive improvement in demand for its ingredients for sun care, cosmetics and hair care markets, growing sales by 11%, but remained constrained by the impact of continued lockdowns in some parts of Asia and Europe. Beauty Formulation had enjoyed resilient sales through pandemic lockdown, with its focus on 'at home' use products, but still delivered 8% growth as lockdowns eased. Innovation is focused on natural ingredients and biotechnology to meet growing consumer demand, with Beauty Actives launching AmeyezingTM, a biodegradable product with its origins in wild ginger that improves the appearance of dark eye circles.

How promising and exciting does this look ? Our products are in a growing market here. Onwards and upwards

Great finish last week, let’s hope for a good start this week. good luck al

Looks like news could we landing any day now from Elrics update, certainly don’t want to be out of this especially as everything seems to be going all to plan especially as Croda are still ahead of schedule.

Yesterday’s sell off was completely uncalled for and those smart enough were quick to buy the shares back.

This downward trend is purely out of boredom and as Elrico’s update yesterday proves that it is nothing company specific. Those selling at yesterday’s stupid prices will only have to buy back at a higher price later.

£1 club soon

I still believe this is a bargain right now and believe in Stuart and the team, you are right patience is needed. Weak can continue to sell, there’s only a 2 weeks left for July to be done and dusted. I will be topping up at these crazy cheap levels

Would be good for us to get some sort of update soon the lack of news is killing this share!